Global Prescription Pain Relievers Market Size, Status and Forecast 2020-2026

Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Prescription Pain Relievers Revenue
• 1.4 Market Analysis by Type
  • 1.4.1 Global Prescription Pain Relievers Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Generic Opioids
  • 1.4.3 Branded Opioids
  • 1.4.4 NSAIDs
  • 1.4.5 Others
• 1.5 Market by Application
  • 1.5.1 Global Prescription Pain Relievers Market Share by Application: 2020 VS 2026
  • 1.5.2 Hospitals
  • 1.5.3 Clinics
  • 1.5.4 Drugstores
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends by Regions

• 2.1 Prescription Pain Relievers Market Perspective (2015-2026)
• 2.2 Prescription Pain Relievers Growth Trends by Regions
  • 2.2.1 Prescription Pain Relievers Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Prescription Pain Relievers Historic Market Share by Regions (2015-2020)
  • 2.2.3 Prescription Pain Relievers Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Prescription Pain Relievers Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Prescription Pain Relievers Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Prescription Pain Relievers Players by Market Size
  • 3.1.1 Global Top Prescription Pain Relievers Players by Revenue (2015-2020)
  • 3.1.2 Global Prescription Pain Relievers Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Prescription Pain Relievers Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Prescription Pain Relievers Market Concentration Ratio
  • 3.2.1 Global Prescription Pain Relievers Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Prescription Pain Relievers Revenue in 2019
• 3.3 Prescription Pain Relievers Key Players Head office and Area Served
• 3.4 Key Players Prescription Pain Relievers Product Solution and Service
• 3.5 Date of Enter into Prescription Pain Relievers Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

• 4.1 Global Prescription Pain Relievers Historic Market Size by Type (2015-2020)
• 4.2 Global Prescription Pain Relievers Forecasted Market Size by Type (2021-2026)

5 Prescription Pain Relievers Breakdown Data by Application (2015-2026)

• 5.1 Global Prescription Pain Relievers Market Size by Application (2015-2020)
• 5.2 Global Prescription Pain Relievers Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Prescription Pain Relievers Market Size (2015-2020)
• 6.2 Prescription Pain Relievers Key Players in North America (2019-2020)
• 6.3 North America Prescription Pain Relievers Market Size by Type (2015-2020)
• 6.4 North America Prescription Pain Relievers Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Prescription Pain Relievers Market Size (2015-2020)
• 7.2 Prescription Pain Relievers Key Players in Europe (2019-2020)
• 7.3 Europe Prescription Pain Relievers Market Size by Type (2015-2020)
• 7.4 Europe Prescription Pain Relievers Market Size by Application (2015-2020)

8 China

• 8.1 China Prescription Pain Relievers Market Size (2015-2020)
• 8.2 Prescription Pain Relievers Key Players in China (2019-2020)
• 8.3 China Prescription Pain Relievers Market Size by Type (2015-2020)
• 8.4 China Prescription Pain Relievers Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Prescription Pain Relievers Market Size (2015-2020)
• 9.2 Prescription Pain Relievers Key Players in Japan (2019-2020)
• 9.3 Japan Prescription Pain Relievers Market Size by Type (2015-2020)
• 9.4 Japan Prescription Pain Relievers Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Prescription Pain Relievers Market Size (2015-2020)
• 10.2 Prescription Pain Relievers Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Prescription Pain Relievers Market Size by Type (2015-2020)
• 10.4 Southeast Asia Prescription Pain Relievers Market Size by Application (2015-2020)

11 India

• 11.1 India Prescription Pain Relievers Market Size (2015-2020)
• 11.2 Prescription Pain Relievers Key Players in India (2019-2020)
• 11.3 India Prescription Pain Relievers Market Size by Type (2015-2020)
• 11.4 India Prescription Pain Relievers Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Prescription Pain Relievers Market Size (2015-2020)
• 12.2 Prescription Pain Relievers Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Prescription Pain Relievers Market Size by Type (2015-2020)
• 12.4 Central & South America Prescription Pain Relievers Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Pfizer
  • 13.1.1 Pfizer Company Details
  • 13.1.2 Pfizer Business Overview and Its Total Revenue
  • 13.1.3 Pfizer Prescription Pain Relievers Introduction
  • 13.1.4 Pfizer Revenue in Prescription Pain Relievers Business (2015-2020))
  • 13.1.5 Pfizer Recent Development
• 13.2 GSK
  • 13.2.1 GSK Company Details
  • 13.2.2 GSK Business Overview and Its Total Revenue
  • 13.2.3 GSK Prescription Pain Relievers Introduction
  • 13.2.4 GSK Revenue in Prescription Pain Relievers Business (2015-2020)
  • 13.2.5 GSK Recent Development
• 13.3 Grunenthal
  • 13.3.1 Grunenthal Company Details
  • 13.3.2 Grunenthal Business Overview and Its Total Revenue
  • 13.3.3 Grunenthal Prescription Pain Relievers Introduction
  • 13.3.4 Grunenthal Revenue in Prescription Pain Relievers Business (2015-2020)
  • 13.3.5 Grunenthal Recent Development
• 13.4 Bayer
  • 13.4.1 Bayer Company Details
  • 13.4.2 Bayer Business Overview and Its Total Revenue
  • 13.4.3 Bayer Prescription Pain Relievers Introduction
  • 13.4.4 Bayer Revenue in Prescription Pain Relievers Business (2015-2020)
  • 13.4.5 Bayer Recent Development
• 13.5 Sanofi
  • 13.5.1 Sanofi Company Details
  • 13.5.2 Sanofi Business Overview and Its Total Revenue
  • 13.5.3 Sanofi Prescription Pain Relievers Introduction
  • 13.5.4 Sanofi Revenue in Prescription Pain Relievers Business (2015-2020)
  • 13.5.5 Sanofi Recent Development
• 13.6 Eli Lilly
  • 13.6.1 Eli Lilly Company Details
  • 13.6.2 Eli Lilly Business Overview and Its Total Revenue
  • 13.6.3 Eli Lilly Prescription Pain Relievers Introduction
  • 13.6.4 Eli Lilly Revenue in Prescription Pain Relievers Business (2015-2020)
  • 13.6.5 Eli Lilly Recent Development
• 13.7 AstraZeneca
  • 13.7.1 AstraZeneca Company Details
  • 13.7.2 AstraZeneca Business Overview and Its Total Revenue
  • 13.7.3 AstraZeneca Prescription Pain Relievers Introduction
  • 13.7.4 AstraZeneca Revenue in Prescription Pain Relievers Business (2015-2020)
  • 13.7.5 AstraZeneca Recent Development
• 13.8 Endo
  • 13.8.1 Endo Company Details
  • 13.8.2 Endo Business Overview and Its Total Revenue
  • 13.8.3 Endo Prescription Pain Relievers Introduction
  • 13.8.4 Endo Revenue in Prescription Pain Relievers Business (2015-2020)
  • 13.8.5 Endo Recent Development
• 13.9 Merck
  • 13.9.1 Merck Company Details
  • 13.9.2 Merck Business Overview and Its Total Revenue
  • 13.9.3 Merck Prescription Pain Relievers Introduction
  • 13.9.4 Merck Revenue in Prescription Pain Relievers Business (2015-2020)
  • 13.9.5 Merck Recent Development
• 13.10 Depomed
  • 13.10.1 Depomed Company Details
  • 13.10.2 Depomed Business Overview and Its Total Revenue
  • 13.10.3 Depomed Prescription Pain Relievers Introduction
  • 13.10.4 Depomed Revenue in Prescription Pain Relievers Business (2015-2020)
  • 13.10.5 Depomed Recent Development
• 13.11 Yunnan Baiyao
  • 10.11.1 Yunnan Baiyao Company Details
  • 10.11.2 Yunnan Baiyao Business Overview and Its Total Revenue
  • 10.11.3 Yunnan Baiyao Prescription Pain Relievers Introduction
  • 10.11.4 Yunnan Baiyao Revenue in Prescription Pain Relievers Business (2015-2020)
  • 10.11.5 Yunnan Baiyao Recent Development
• 13.12 Teva
  • 10.12.1 Teva Company Details
  • 10.12.2 Teva Business Overview and Its Total Revenue
  • 10.12.3 Teva Prescription Pain Relievers Introduction
  • 10.12.4 Teva Revenue in Prescription Pain Relievers Business (2015-2020)
  • 10.12.5 Teva Recent Development
• 13.13 J&J
  • 10.13.1 J&J Company Details
  • 10.13.2 J&J Business Overview and Its Total Revenue
  • 10.13.3 J&J Prescription Pain Relievers Introduction
  • 10.13.4 J&J Revenue in Prescription Pain Relievers Business (2015-2020)
  • 10.13.5 J&J Recent Development
• 13.14 Allergan
  • 10.14.1 Allergan Company Details
  • 10.14.2 Allergan Business Overview and Its Total Revenue
  • 10.14.3 Allergan Prescription Pain Relievers Introduction
  • 10.14.4 Allergan Revenue in Prescription Pain Relievers Business (2015-2020)
  • 10.14.5 Allergan Recent Development
• 13.15 Purdue
  • 10.15.1 Purdue Company Details
  • 10.15.2 Purdue Business Overview and Its Total Revenue
  • 10.15.3 Purdue Prescription Pain Relievers Introduction
  • 10.15.4 Purdue Revenue in Prescription Pain Relievers Business (2015-2020)
  • 10.15.5 Purdue Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer